Marianna Talia
Rende, 87036, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Stress-Inducible Transcription Factor NUPR1 Is Involved in the Inhibitory Effects Exerted by Statins on Insulin Action in ER-Positive Breast Cancer Cells.
Journal: Cells
Published: December 19, 2025
Stress-Inducible Transcription Factor NUPR1 Is Involved in the Inhibitory Effects Exerted by Statins on Insulin Action in ER-Positive Breast Cancer Cells.
Journal: Cells
Published: December 19, 2025
Alternate actions of CDK4/6 inhibitors beyond cell cycle blockade: unexplored roles in therapy resistance.
Journal: Cancer metastasis reviews
Published: August 18, 2025
A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors.
Journal: Journal of translational medicine
Published: August 06, 2025
Integrating trajectory inference and self-explainable predictive models to explore cell state transitions in breast cancer at single-cell resolution.
Journal: Frontiers in bioinformatics
Published: July 24, 2025
Interleukin-1β mediates a tumor-supporting environment prompted by IGF1 in triple-negative breast cancer (TNBC).
Journal: Journal of translational medicine
Published: May 22, 2025
PARP-1 as a novel target in endocrine-resistant breast cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 23, 2025
Harnessing sample preparation for RNA-sequencing toward a reliable bioinformatics analysis.
Journal: Journal of translational medicine
Published: July 31, 2024
Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients.
Journal: Journal of translational medicine
Published: May 29, 2024
Estetrol/GPER/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells.
Journal: Journal of translational medicine
Published: April 08, 2024
The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 19, 2024
Publisher Correction: RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer.
Journal: Breast cancer research : BCR
Published: August 10, 2023
Last Updated: 09/26/2026